Money Concepts Capital’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,414
Closed -$507K 405
2024
Q2
$507K Sell
17,414
-465
-3% -$13.8K 0.04% 287
2024
Q1
$634K Buy
17,879
+869
+5% +$34.8K 0.06% 261
2023
Q4
$741K Buy
17,010
+970
+6% +$38.2K 0.07% 230
2023
Q3
$613K Buy
16,040
+7,334
+84% +$309K 0.06% 232
2023
Q2
$358K Buy
8,706
+97
+1% +$4.67K 0.04% 289
2023
Q1
$494K Sell
8,609
-21
-0.2% -$1.18K 0.03% 289
2022
Q4
$484K Sell
8,630
-465
-5% -$23.7K 0.02% 441
2022
Q3
$385K Buy
9,095
+205
+2% +$10.5K 0.02% 330
2022
Q2
$489K Buy
8,890
+919
+12% +$55.2K 0.04% 284
2022
Q1
$512K Buy
7,971
+168
+2% +$11.1K 0.03% 432
2021
Q4
$523K Buy
+7,803
New +$528K 0.04% 307
2021
Q1
$547K Sell
7,911
-55
-0.7% -$3.73K 0.04% 299
2020
Q4
$517K Buy
+7,966
New +$429K 0.05% 280

Other funds holding IART

Money Concepts Capital's IART Position: Q3 2024 in Review

Money Concepts Capital sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 17,414 shares — an estimated $507K sold.

Money Concepts Capital first reported a position in IART in Q4 2020 and held it in 13 quarters. The position peaked at $741K in Q4 2023. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Money Concepts Capital reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Money Concepts Capital sold 17,414 Integra LifeSciences shares in Q3 2024, an estimated $507K.
  • Money Concepts Capital first reported a position in Integra LifeSciences in Q4 2020 and held it in 13 quarters.
  • Money Concepts Capital's Integra LifeSciences position peaked at $741K in Q4 2023.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Money Concepts Capital's 13F filing for Q3 2024, filed 31 Oct 2024.